Bioaccess Ivs
CVE-2023-38955
HIGH
Vulnerability Assessment
| Weakness |
CWE
OWASP Top 10:2025
A01:2025 - Broken Access Control
ASVS 5.0
V8 - Authorization Resource sphere isolation
MITRE ATT&CK
1 technique across 1 tactic: Collection The technique list with ATT&CK links and the kill-chain view is part of the Basic plan and up. |
| Impact | CVSS score of 7.5 (HIGH). Attack characteristics: network attack vector, low complexity, no privileges required, no user interaction not required. EPSS exploitation probability: 0.50%. |
| Exploit ScenarioDerived | A remote attacker could access resources from an unintended security context by sending crafted requests to the affected application. No authentication is required to exploit this vulnerability. |
Get an e-mail when this CVE is exploited, patched or re-scored. Free account.
Alert meAnalysisAI
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
RemediationAI
No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Implement proper access controls, validate resource access permissions, use security boundaries.
Affects your stack
Find out whether the stacks and servers you run are on an affected version.
Checking this CVE against your own stacks and servers is part of the Basic plan and up.
Technical ContextAI · show details
This vulnerability is classified as Exposure of Resource to Wrong Sphere (CWE-668), which allows attackers to access resources from an unintended security context. ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names. Affected products include: Zkteco Bioaccess Ivs.
Know when Bioaccess Ivs gets its next vulnerability
- Watch products and get an email when something new is published
- Check this CVE against your own stack and servers
- Exploit and PoC references, threat intelligence from 22 sources
No credit card · 7-day full trial
Severity by source
AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Primary rating from NVD · only source for this CVE.
CVSS VectorNVD
DescriptionNVD
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
Threat Intelligence Overview
How this decision was reached
The engine reads each signal below and applies a fixed list of rules from top to bottom. The first rule that matches sets the recommended action – like a statement, every line is shown.
What every action level means
SSVC AssessmentENISA
Priority Score
Attack Technique
Information disclosure occurs when an application unintentionally exposes sensitive data that aids attackers in reconnaissance or directly compromises security.
Affected Products (CPE)NVD
More in Bioaccess Ivs
View allZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability. Rated critical severity (CVSS 9.8),
A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files v
An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open th
NVD
CVE.org
EPSS
VulDB
GitHub PoC
Exploit-DB